| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 11/25/2010 | US20100298370 Benzothiazolyl thienopyridine derivatives and uses thereof |
| 11/25/2010 | US20100298368 Antagonists of pgd2 receptors |
| 11/25/2010 | US20100298361 Alkylthio Pyrimidines As CRTH2 Antagonists |
| 11/25/2010 | US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors |
| 11/25/2010 | US20100298348 Method of Decreasing Ubiquitylated Protein Levels |
| 11/25/2010 | US20100298344 Polycationic Compounds And Uses Thereof |
| 11/25/2010 | US20100298337 Organic Compounds |
| 11/25/2010 | US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use |
| 11/25/2010 | US20100298315 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmnaceutical compositions and novel use as met inhibitors |
| 11/25/2010 | US20100298314 Novel jnk inhibitors |
| 11/25/2010 | US20100298309 Tricyclic triazolic compounds |
| 11/25/2010 | US20100298308 Compositions and methods for bone formation and remodeling |
| 11/25/2010 | US20100298300 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 11/25/2010 | US20100298298 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof |
| 11/25/2010 | US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 11/25/2010 | US20100298286 Organic Compounds |
| 11/25/2010 | US20100298285 Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof |
| 11/25/2010 | US20100298269 Prodrugs of cgrp receptor antagonists |
| 11/25/2010 | US20100298265 Inclusion complex of raloxifene hydrochloride and beta-cyclodextrin |
| 11/25/2010 | US20100298248 Biologically active macrolides, compositions, and uses thereof |
| 11/25/2010 | US20100298239 Peptide with multiple epitopes |
| 11/25/2010 | US20100298236 Soluble gp130 muteins with improved binding activity |
| 11/25/2010 | US20100298232 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
| 11/25/2010 | US20100298229 Osteoprotegerin |
| 11/25/2010 | US20100298228 Bone-reinforcing food material |
| 11/25/2010 | US20100298227 Treatment of autoimmune conditions with Copolymer 1 and related copolymers |
| 11/25/2010 | US20100298201 Peptidomimetic macrocycles with improved properties |
| 11/25/2010 | US20100298200 Compounds and assays for controlling Wnt activity |
| 11/25/2010 | US20100297255 Malleable implants containing demineralized bone matrix |
| 11/25/2010 | US20100297254 Nutraceutical composition and methods of use |
| 11/25/2010 | US20100297239 Osseointegrative meniscus and cartilage implants based on beta-glucan nanocomposites |
| 11/25/2010 | US20100297233 Oscillating cell culture bioreactor |
| 11/25/2010 | US20100297221 pharmaceutical composition of tacrolimus |
| 11/25/2010 | US20100297210 Repair and treatment of bone defect using agent produced by chondrocytes capable of hypertrophication and scaffold |
| 11/25/2010 | US20100297196 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 11/25/2010 | US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 11/25/2010 | US20100297119 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 11/25/2010 | US20100297111 Nanobodies against tumor necrosis factor-alpha |
| 11/25/2010 | US20100297096 Amphiphilic peptide matrices for treatment of osteoporosis |
| 11/25/2010 | US20100297088 Methods for Culturing Minimally-Passaged Fibroblasts and Uses Thereof |
| 11/25/2010 | US20100297082 Weight-bearing polyurethane composites and methods thereof |
| 11/25/2010 | US20100297046 Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors |
| 11/25/2010 | US20100297024 Promoter inducible by reactive oxygen species and vector comprising the same |
| 11/25/2010 | US20100297021 Variants of C-Type Natriuretic Peptide |
| 11/25/2010 | CA2763283A1 Phytases, nucleic acids encoding them and methods for making and using them |
| 11/25/2010 | CA2758581A1 Variants of c-type natriuretic peptide |
| 11/24/2010 | EP2253627A1 Inclusion complex of raloxifene hydrochloride and beta-cyclodextrin. |
| 11/24/2010 | EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 11/24/2010 | EP2253311A2 Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, as well as combination therapy relating thereto |
| 11/24/2010 | EP2252615A1 Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 11/24/2010 | EP2252585A1 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 11/24/2010 | EP2252302A1 Composition for the treatment of osteoarthritis |
| 11/24/2010 | EP2252290A1 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 11/24/2010 | EP1891006B1 Inhibitors of cytosolic phospholipase a2 |
| 11/24/2010 | EP1603917B1 Immunomodulating heterocyclic compounds |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 11/24/2010 | EP1423082B1 Plasma protein matrices and methods for their preparation |
| 11/24/2010 | EP1326896B1 Human anti-cd40 antibodies |
| 11/24/2010 | EP1276486B1 Joint repair using mesenchymal stem cells |
| 11/24/2010 | CN201642995U Bone knitting pill |
| 11/24/2010 | CN201640466U Health-care underpants |
| 11/24/2010 | CN101896501A Antibody targeting osteoclast-related protein Siglec-15 |
| 11/24/2010 | CN101896201A Method for treating bone fracture with anti-sclerostin antibodies |
| 11/24/2010 | CN101892249A Pufa polyketide synthase systems and uses thereof |
| 11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
| 11/24/2010 | CN101891803A New cartilaginous affinity polypeptide sequence, screening method and application thereof |
| 11/24/2010 | CN101891738A Dasatinib polymorph and preparation method and medical composite thereof |
| 11/24/2010 | CN101891726A Iguratimod crystalline form and composite thereof |
| 11/24/2010 | CN101891703A Febuxostat crystal and preparation method and application in medicines thereof |
| 11/24/2010 | CN101891702A Crystal of febuxostat, preparation method and application in medicaments |
| 11/24/2010 | CN101890171A Inclusion complex of raloxifene hydrochloride and beta-cyclodextrin |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101890150A Novel and special Likexiao |
| 11/24/2010 | CN101890149A Formula for treating stiff neck and preparation method thereof |
| 11/24/2010 | CN101890127A New application of HuGu capsule in preventing glucocorticoid-induced osteoporosis |
| 11/24/2010 | CN101890122A Medicament for treating bone diseases |
| 11/24/2010 | CN101890121A External medicinal composition for treating acute soft tissue injury and preparation method and application thereof |
| 11/24/2010 | CN101890104A Chinese medicament for treating neck, shoulder, waist and leg pains |
| 11/24/2010 | CN101890089A Formula for treating periarthritis of shoulder and preparation method thereof |
| 11/24/2010 | CN101890084A Semen nigellae total glycoside extract and preparation method and application thereof |
| 11/24/2010 | CN101890078A Traditional Chinese medicinal tablets for treating lumbar spinal stenosis and production method thereof |
| 11/24/2010 | CN101890072A Skelalgia powder for treating cold dampness leg |
| 11/24/2010 | CN101890069A Medicament for preventing and treating gout and preparation process thereof |
| 11/24/2010 | CN101890068A Injection for treating fracture and preparation method thereof |
| 11/24/2010 | CN101890058A Health-care bio-chip based on nano-taxus and preparation method thereof |
| 11/24/2010 | CN101890026A Water soluble vitamin D2 and calcium colloid injection medicinal composition |
| 11/24/2010 | CN101889967A Shampoo or hair conditioner additive and method for preparing same |
| 11/24/2010 | CN101889946A Smokeless black bean moxibustion instrument |
| 11/24/2010 | CN101235097B Method for extracting polysaccharide from angelica and application thereof |
| 11/24/2010 | CN101233105B Tryptophan derivative and use thereof |
| 11/24/2010 | CN101229334B Medicine for treating rheumatoid and atrophic arthritis |
| 11/24/2010 | CN101229244B Adjuvant therapy rheumatoid arthritis external medicine and preparing method thereof |
| 11/24/2010 | CN101095729B Medicine for treating lumbar intervertebral disc protrusion |
| 11/24/2010 | CN101062022B Colchicine patch absorbing from skin for treating acute goute arthritis and the preparing method thereof |
| 11/23/2010 | US7838675 Asthma, allergic rhinitis, COPD, inflammatory bowel disease, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis, or cancer; N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-[2-hydroxy-1-(hydroxymethyl)ethoxy]-4-pyrimidinyl]-1-azetidinesulfonamide for example |
| 11/23/2010 | US7838644 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 11/23/2010 | US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 11/23/2010 | US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |